Fermenta Biotech Ranked Among India's Best Workplaces
Fermenta Biotech Ltd. has been recognized as one of India's Best Workplaces in Pharmaceuticals, Healthcare & Biotech 2024 by Great Place To Work. Discover what makes their culture stand out.
Category : Search result: Fermenta Biotech
Orange Biotech PCD Pharma Franchise: Lucrative Business Opportunity
Orange Biotech Private Limited unveils a nationwide PCD pharma franchise with high-profit margins, monopoly rights, and extensive product portfolio for entrepreneurs. Start your own pharma business today!
Key Stocks to Watch: Concord, Ambuja, Paytm, Groww, Cipla
Concord Biotech's block deal, Ambuja Cements' acquisition, Paytm's new CEO, and Groww's funding round are among the top market movers today. Get the full analysis.
Biocon Merges Biologics Unit, Plans Rs 4,500 Cr Fundraise
Biocon announces merger of its biologics subsidiary with the parent company and a major Rs 4,500 crore fundraise. Explore the strategic shift and its impact on India's biotech sector.
Odisha Biotech Research Grants: Apply by Dec 10
Odisha's Science Dept invites faculty & researchers for biotech R&D grants up to Rs 30 lakh. Maximum 10 projects selected yearly. Submit applications before December 10 deadline.
Sandesara Brothers Settlement Exceeds Bank Claims
Fugitive Sandesara brothers offer Rs 5,100 crore settlement, bringing total recovery to Rs 9,800 crore - far exceeding banks' Rs 6,700 crore demand. ED celebrates biggest PMLA recovery.
SC allows Sandesara brothers to settle fraud case for ₹5,100 cr
Supreme Court permits Sandesara brothers to settle massive bank fraud case with ₹5,100 crore payment. Historic decision marks first criminal case closure after settlement. Read full details.
SC clears ₹5,100 crore Sandesara brothers bank fraud settlement
Supreme Court approves ₹5,100 crore settlement by fugitive Sandesara brothers in massive bank fraud case. All criminal proceedings to be dropped upon payment completion by December 2025.
SC accepts Sterling Biotech's Rs 5,100 crore fraud settlement
Supreme Court agrees to drop criminal proceedings against Sterling Biotech promoters in bank fraud case upon payment of Rs 5,100 crore by December 17, 2025. Full case details inside.
India's Biotech to Hit $1.2 Trillion by 2047
India's biotechnology sector is projected to become a $1.2 trillion industry by 2047, driven by vaccines, diagnostics, and bio-agriculture. Discover how this growth will transform healthcare and agriculture.
US Panel Flags China Risks in Key Tech Supply Chains
A US commission warns Congress of China's growing leverage in biotech, quantum computing, and legacy semiconductors, urging action to prevent supply chain weaponization. Read the full report.
Bharat Biotech enters cell & gene therapy with Nucelion
Indian vaccine maker Bharat Biotech expands into high-growth CRDMO space with new subsidiary Nucelion Therapeutics, focusing on cutting-edge cell and gene therapies for cancer and rare diseases.
Health Biotech Expands Global Presence at CPhI Frankfurt
Indian biopharmaceutical leader Health Biotech Limited makes waves at CPhI Frankfurt 2025, showcasing innovative products and forging international partnerships to strengthen its global market position.
US Push for Affordable Biotech Drugs: India's Opportunity
Federal health officials are accelerating efforts to bring cheaper biotech drugs to market, potentially transforming treatment access and creating new opportunities for Indian pharmaceutical companies.
CRISPR Therapy Paused After Patient Liver Reaction
In a significant setback for gene editing medicine, Intellia Therapeutics halts its Phase 3 ATTR trial following a serious liver adverse event in a patient receiving CRISPR-based treatment NZ-1.
Novartis Nears $1.7B Avidity Biosciences Acquisition
Swiss pharmaceutical giant Novartis AG is finalizing a landmark acquisition of California-based Avidity Biosciences in a deal valuing the biotech firm at over $70 per share, potentially exceeding $1.7 billion, according to exclusive reports.
Page 1 of 1